Literature DB >> 24122280

Detective value of historical height loss and current height/knee height ratio for prevalent vertebral fracture in Japanese postmenopausal women.

Kousei Yoh, Akiko Kuwabara, Kiyoshi Tanaka.   

Abstract

Vertebral fracture (VFx) is associated with various co-morbidities and increased mortality. In this paper, we have studied the detective value of height loss for VFx using two indices; historical height loss (HHL) which is the difference between the maximal height, and the current height (CH), and CH/knee height (KH) ratio. One-hundred and fifty-one postmenopausal women visiting the outpatient clinic of orthopaedics were studied for their CH, self-reported maximal height, KH, and radiographically diagnosed VFx number(s). VFx was present in 41.1 % of the subjects. Multiple regression analyses revealed that the number of prevalent fractures was a significant predictor of HHL and CH/KH ratio. Receiver operator characteristic curve analysis has shown that for HHL, the area under the curve (AUC) with their 95 %CI in the parentheses was 0.84 (0.77, 0.90), 0.88 (0.83, 0.94), and 0.91 (0.86, 0.96) for ≥ 1, ≥ 2, and ≥ 3 fractures, respectively. For the presence of ≥ 1 VFx, the cut-off value was 4.0 cm (specificity 79 %; sensitivity 79 %). Regarding the CH/KH ratio, AUC was 0.73 (0.65, 0.82), 0.85 (0.78, 0.93), and 0.91 (0.86, 0.96) for ≥ 1, ≥ 2, and ≥ 3 fractures, respectively. For the presence of ≥ 1 VFx, the cut-off value was 3.3 (specificity 47 %; sensitivity 91 %). Both cut-off values for HHL and CH/KH ratio had high negative predictivity across the wide range of theoretical VFx prevalence. Thus, HHL and CH/KH were both good detectors of VFx. Our data would be the basis to determine the cut-off value for the screening or case finding of subjects with VFx.

Entities:  

Mesh:

Year:  2014        PMID: 24122280     DOI: 10.1007/s00774-013-0525-y

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  36 in total

1.  The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada.

Authors:  J D Adachi; G Loannidis; C Berger; L Joseph; A Papaioannou; L Pickard; E A Papadimitropoulos; W Hopman; S Poliquin; J C Prior; D A Hanley; W P Olszynski; T Anastassiades; J P Brown; T Murray; S A Jackson; A Tenenhouse
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

2.  Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  T M Vogt; P D Ross; L Palermo; T Musliner; H K Genant; D Black; D E Thompson
Journal:  Mayo Clin Proc       Date:  2000-09       Impact factor: 7.616

3.  Evaluation of accuracy and reliability of calipers for measuring recumbent knee height in elderly people.

Authors:  D B Cockram; R N Baumgartner
Journal:  Am J Clin Nutr       Date:  1990-08       Impact factor: 7.045

4.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

5.  Mortality after vertebral fracture in Korea: analysis of the National Claim Registry.

Authors:  Y-K Lee; S Jang; S Jang; H J Lee; C Park; Y-C Ha; D-Y Kim
Journal:  Osteoporos Int       Date:  2011-11-23       Impact factor: 4.507

6.  When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS).

Authors:  Stephen Kaptoge; Gabi Armbrecht; Dieter Felsenberg; Mark Lunt; Terence W O'Neill; Alan J Silman; Jonathan Reeve
Journal:  J Bone Miner Res       Date:  2004-09-07       Impact factor: 6.741

7.  Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study.

Authors:  R Hasserius; M K Karlsson; B E Nilsson; I Redlund-Johnell; O Johnell
Journal:  Osteoporos Int       Date:  2003-01       Impact factor: 4.507

8.  The impact of osteoporosis on quality-of-life: the OFELY cohort.

Authors:  A R Martin; E Sornay-Rendu; J M Chandler; F Duboeuf; C J Girman; P D Delmas
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

9.  Impact of spinal kyphosis on gastroesophageal reflux disease symptoms in patients with osteoporosis.

Authors:  N Miyakoshi; Y Kasukawa; H Sasaki; K Kamo; Y Shimada
Journal:  Osteoporos Int       Date:  2008-10-23       Impact factor: 4.507

10.  An evaluation of an enhanced fracture liaison service as the optimal model for secondary prevention of osteoporosis.

Authors:  Ir Wallace; F Callachand; J Elliott; Pv Gardiner
Journal:  JRSM Short Rep       Date:  2011-02-10
View more
  4 in total

1.  Adult spinal deformity and its relationship with height loss: a 34-year longitudinal cohort study.

Authors:  Mutsuya Shimizu; Tetsuya Kobayashi; Hisashi Chiba; Issei Senoo; Hiroshi Ito; Keisuke Matsukura; Senri Saito
Journal:  BMC Musculoskelet Disord       Date:  2020-07-01       Impact factor: 2.362

2.  Associations of self-reported height loss and kyphosis with vertebral fractures in Japanese women 60 years and older: a cross-sectional survey.

Authors:  Mikio Kamimura; Yukio Nakamura; Noriyuki Sugino; Shigeharu Uchiyama; Masatoshi Komatsu; Shota Ikegami; Hiroyuki Kato; Akira Taguchi
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

3.  Implications of historical height loss for prevalent vertebral fracture, spinal osteoarthritis, and gastroesophageal reflux disease.

Authors:  Masaki Nakano; Yukio Nakamura; Takako Suzuki; Tsukasa Kobayashi; Jun Takahashi; Masataka Shiraki
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

4.  Height loss in postmenopausal women-do we need more for fracture risk assessment? Results from the GO Study.

Authors:  W Pluskiewicz; P Adamczyk; B Drozdzowska
Journal:  Osteoporos Int       Date:  2021-04-05       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.